Product image of Comirnaty Omicron Xbb.1.5 (Raxtozinameran) supplied by GNH India

Comirnaty Omicron Xbb.1.5

Active Ingredient:
Raxtozinameran
Origin:
EU

Comirnaty Omicron Xbb.1.5 (Raxtozinameran)

Comirnaty Omicron Xbb.1.5 is a vaccine designed to provide protection against the Omicron Xbb.1.5 variant of COVID-19. This intramuscular injection is manufactured by BioNTech Manufacturing GmbH and is intended for use in eligible individuals.

Manufacturer / TM Owner

Biontech Manufacturing Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Comirnaty Omicron Xbb.1.5 is used to help prevent COVID-19 caused by the Omicron Xbb.1.5 variant. This vaccine is part of a broader effort to enhance immunity and reduce the spread of the virus. It is administered intramuscularly and is designed to stimulate the body's immune response.

Side Effects

  • Common effects of Comirnaty Omicron Xbb.1.5 may include temporary soreness at the injection site, fatigue, headache, and mild fever. These effects are generally mild and short-lived, indicating that the body is building immunity. Severe reactions are rare but should be reported to a healthcare provider.

Precautions & Warnings

  • Before receiving Comirnaty Omicron Xbb.1.5, inform your healthcare provider about any allergies or medical conditions. It is important to follow the recommended storage and handling instructions to maintain the vaccine's effectiveness. Always consult with a healthcare professional for personalized advice.

Avoid Interactions

  • Comirnaty Omicron Xbb.1.5 may interact with certain medications or medical conditions. It is advisable to discuss any current treatments or health issues with a healthcare provider before receiving the vaccine. Avoid taking other vaccines simultaneously unless advised by a healthcare professional.

Frequently Asked Questions

Comirnaty Omicron Xbb.1.5 is used to help prevent COVID-19 caused by the Omicron Xbb.1.5 variant.

Comirnaty Omicron Xbb.1.5 is administered intramuscularly, typically in the upper arm.

Common effects may include temporary soreness at the injection site, fatigue, headache, and mild fever.

Individuals with a history of severe allergic reactions to any component of the vaccine should consult a healthcare provider before receiving Comirnaty Omicron Xbb.1.5.

It is advisable to discuss any current medications with a healthcare provider before receiving Comirnaty Omicron Xbb.1.5.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Raxtozinameran

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT